Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.5265
Delayed Data
As of Dec 06
 +0.0269 / +5.38%
Today’s Change
0.41
Today|||52-Week Range
3.66
-80.13%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.50
Today’s open0.50
Day’s range0.49 - 0.53
Volume1,151,706
Average volume (3 months)1,254,002
Market cap$50.0M
Dividend yield--
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
MTFBMotif Bio PLC+0.10+1.80%
DNAIProNAi Therapeutics ...+0.05+3.38%
TENXTenax Therapeutics I...-0.04-2.04%
KMPHKemPharm Inc0.000.00%
Data as of 12/06/2016

Financials

Last reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts


Search for Jobs